Search Results

Tadalafil improves lower urinary tract symptoms in patients with benign prostatic hyperplasia

Source: Inpharma, Volume 1, Number 1510, 2005-10-22 , pp. 18-18(1)

Publisher: Adis International

For the second time this year, sales of the erectile dysfunction therapy tadalafil [Cialis] in France have surpassed those of the traditional market leader sildenafil [Viagra]

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 477, 2005-05-07 , pp. 14-14(1)

Publisher: Adis International

Tadalafil improves erectile function in men with both erectile dysfunction and benign prostatic hyperplasia (BPH)

Source: Inpharma, Volume 1, Number 1461, 2004-10-30 , pp. 14-14(1)

Publisher: Adis International

Eli Lilly's erectile dysfunction (ED) treatment tadalafil [Cialis] has already captured a significant share of new US prescriptions in the class, despite being on the market for only 3 months.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 450, 2004-04-10 , pp. 15-15(1)

Publisher: Adis International

Tadalafil appears to improve erections in difficult-to-treat patients who have undergone prostatectomy

Source: Inpharma, Volume 1, Number 1409, 2003 , pp. 15-15(1)

Publisher: Adis International

Tadalafil [`Cialis'; Lilly ICOS LLC] has been launched in Mexico

Source: Inpharma, Volume 1, Number 1403, 2003 , pp. 18-18(1)

Publisher: Adis International

Tadalafil [`Cialis'; Lilly ICOS LLC] is now available in Australia and New Zealand

Source: Inpharma, Volume 1, Number 1374, 2003 , pp. 22-22(1)

Publisher: Adis International